163 related articles for article (PubMed ID: 11446652)
1. Complement factor H: physiology and pathophysiology.
Zipfel PF
Semin Thromb Hemost; 2001 Jun; 27(3):191-9. PubMed ID: 11446652
[TBL] [Abstract][Full Text] [Related]
2. The complement fitness factor H: role in human diseases and for immune escape of pathogens, like pneumococci.
Zipfel PF; Hallström T; Hammerschmidt S; Skerka C
Vaccine; 2008 Dec; 26 Suppl 8():I67-74. PubMed ID: 19388168
[TBL] [Abstract][Full Text] [Related]
3. Complement factor H and hemolytic uremic syndrome.
Zipfel PF; Skerka C; Caprioli J; Manuelian T; Neumann HH; Noris M; Remuzzi G
Int Immunopharmacol; 2001 Mar; 1(3):461-8. PubMed ID: 11367530
[TBL] [Abstract][Full Text] [Related]
4. The simple design of complement factor H: Looks can be deceiving.
Alexander JJ; Quigg RJ
Mol Immunol; 2007 Jan; 44(1-3):123-32. PubMed ID: 16919753
[TBL] [Abstract][Full Text] [Related]
5. The human complement factor H: functional roles, genetic variations and disease associations.
Rodríguez de Córdoba S; Esparza-Gordillo J; Goicoechea de Jorge E; Lopez-Trascasa M; Sánchez-Corral P
Mol Immunol; 2004 Jun; 41(4):355-67. PubMed ID: 15163532
[TBL] [Abstract][Full Text] [Related]
6. Factor H family proteins and human diseases.
Józsi M; Zipfel PF
Trends Immunol; 2008 Aug; 29(8):380-7. PubMed ID: 18602340
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome.
Vaziri-Sani F; Holmberg L; Sjöholm AG; Kristoffersson AC; Manea M; Frémeaux-Bacchi V; Fehrman-Ekholm I; Raafat R; Karpman D
Kidney Int; 2006 Mar; 69(6):981-8. PubMed ID: 16528247
[TBL] [Abstract][Full Text] [Related]
8. Factor H and disease: a complement regulator affects vital body functions.
Zipfel PF; Hellwage J; Friese MA; Hegasy G; Jokiranta ST; Meri S
Mol Immunol; 1999; 36(4-5):241-8. PubMed ID: 10403477
[TBL] [Abstract][Full Text] [Related]
9. Pathological aspects of membranoproliferative glomerulonephritis (MPGN) and haemolytic uraemic syndrome (HUS) / thrombocytic thrombopenic purpura (TTP).
Benz K; Amann K
Thromb Haemost; 2009 Feb; 101(2):265-70. PubMed ID: 19190808
[TBL] [Abstract][Full Text] [Related]
10. Complement factor H and haemolytic uraemic syndrome.
Mathieson P
Lancet; 2002 Mar; 359(9308):801-2. PubMed ID: 11888630
[No Abstract] [Full Text] [Related]
11. Factor H and the pathogenesis of renal diseases.
Ault BH
Pediatr Nephrol; 2000 Sep; 14(10-11):1045-53. PubMed ID: 10975323
[TBL] [Abstract][Full Text] [Related]
12. Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells.
Heinen S; Józsi M; Hartmann A; Noris M; Remuzzi G; Skerka C; Zipfel PF
J Am Soc Nephrol; 2007 Feb; 18(2):506-14. PubMed ID: 17229916
[TBL] [Abstract][Full Text] [Related]
13. [Factor H deficiency].
Kanemitsu S; Hara T
Ryoikibetsu Shokogun Shirizu; 2000; (32):218-20. PubMed ID: 11212697
[No Abstract] [Full Text] [Related]
14. An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations.
Saunders RE; Goodship TH; Zipfel PF; Perkins SJ
Hum Mutat; 2006 Jan; 27(1):21-30. PubMed ID: 16281287
[TBL] [Abstract][Full Text] [Related]
15. Three kidneys, two diseases, one antibody?
Lorcy N; Rioux-Leclercq N; Lombard ML; Le Pogamp P; Vigneau C
Nephrol Dial Transplant; 2011 Nov; 26(11):3811-3. PubMed ID: 21813829
[TBL] [Abstract][Full Text] [Related]
16. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
[TBL] [Abstract][Full Text] [Related]
17. [The role of complement in physiology and pathology].
Klaska I; Nowak JZ
Postepy Hig Med Dosw (Online); 2007; 61():167-77. PubMed ID: 17410057
[TBL] [Abstract][Full Text] [Related]
18. The spectrum of phenotypes caused by variants in the CFH gene.
Boon CJ; van de Kar NC; Klevering BJ; Keunen JE; Cremers FP; Klaver CC; Hoyng CB; Daha MR; den Hollander AI
Mol Immunol; 2009 May; 46(8-9):1573-94. PubMed ID: 19297022
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies in haemolytic uraemic syndrome (HUS).
Skerka C; Józsi M; Zipfel PF; Dragon-Durey MA; Fremeaux-Bacchi V
Thromb Haemost; 2009 Feb; 101(2):227-32. PubMed ID: 19190803
[TBL] [Abstract][Full Text] [Related]
20. Hemolytic uremic syndrome revisited: Shiga toxin, factor H, and fibrin generation.
Blackall DP; Marques MB
Am J Clin Pathol; 2004 Jun; 121 Suppl():S81-8. PubMed ID: 15298153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
